News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update And Investor Presentation On December 4 Through A Live, Interactive Webcast 11/21/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Pricing Of Common Stock Offering 11/21/2014
Agilent Technologies Inc. (A) Announces Cash Dividend Of 10 Cents Per Share 11/21/2014
ZS Pharma (ZSPH) Hosts And Webcasts Investor Event 11/20/2014
StemCells Inc. (STEM)To Host Inaugural Investor And Analyst Event In New York 11/20/2014
Matinas BioPharma To Present At Two Investor Conferences In Early December 11/20/2014
MYOS (MYOS) Announces $1.81 Million Registered Direct Offering 11/20/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/20/2014
Rockwell Medical (RMTI) Prices $58.5 Million Public Offering Of Common Stock 11/20/2014
EXCLUSIVE: Ackman Says “Biggest Mistake” In Allergan (AGN) Bid Was Tender Offer 11/20/2014
Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares 11/20/2014
Organovo Holdings, Inc. To Provide Corporate Update And Investor Presentation In A Live, Interactive Webcast On December 4 11/20/2014
Immune Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/20/2014
Cipher Pharmaceuticals (DND.TO) To Commence Trading On The NASDAQ Global Market 11/20/2014
Valeant (VRX) Announces New $2 Billion Securities Repurchase Program 11/20/2014
Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Receptos (RCPT) Announces Pricing Of Underwritten Public Offering Of Common Stock 11/19/2014
Amicus Therapeutics, Inc. (FOLD) Prices Underwritten Offering Of Common Stock 11/19/2014
SYGNIS Pharma AG Release: GBC Research Reiterates “BUY” Recommendation For SYGNIS Shares With Price Target Of €4.05 11/19/2014
Immune Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/19/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Proposed Convertible Senior Notes Offering 11/19/2014
Amicus Therapeutics, Inc. (FOLD) Announces Public Offering Of Common Stock 11/19/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue – November 19, 2014 11/19/2014
Daxor Corporation (DXR) Announces Payment Of A Dividend 11/19/2014
Zoetis (ZTS) Announces Authorization Of $500 Million Share Repurchase Program 11/18/2014
Paulson Opens New Stake In AbbVie (ABBV), Nearly Triples Shire Shares 11/18/2014
Rockwell Medical (RMTI) Announces $55 Million Proposed Public Offering Of Common Stock 11/18/2014
Horizon Pharma plc.  (HZNP) Announces Pricing Of Secondary Offering Of Ordinary Shares By Selling Shareholders 11/18/2014
PRA Health Sciences Announces Successful Closing Of Its Initial Public Offering 11/18/2014
Best Value In Biotech? Actavis (ACT), Says UBS 11/17/2014
Forward Pharma (FWP) Announces Closing Of Partial Exercise Of Over-Allotment Option 11/17/2014
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014
Alcobra (ADHD) Announces Third Quarter Financial Results And Provides Corporate Update 11/17/2014
Nephros Inc. (NEP) Reports Third Quarter 2014 Financial Results And Announces Launch Of Rights Offering 11/17/2014
Actavis (ACT) Successfully Completes Durata Therapeutics, Inc.  (DRTX) Tender Offer 11/17/2014
ISI: Merck & Co. (MRK)’s Zetia News The Rising Tide To Lift All LDL Boats 11/17/2014
Hemispherx Biopharma (HEB) Reports on Annual Stockholder Meeting 11/17/2014
Bacterin International, Inc. Receives Delisting Notice From NYSE MKT 11/17/2014
If Investors Like Merck & Co. (MRK)'s Zetia Results, They Will Love Esperion Therapeutics, Inc. (ESPR)’s, Says Citi 11/17/2014
Amarantus To Host Business Update Conference Call On November 18, 2014 11/17/2014
Receptos (RCPT) Announces Proposed Underwritten Public Offering Of Common Stock 11/17/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 11/17/2014
Can-Fite BioPharma (CFBI) Announces Special General Meeting Of Shareholders To Elect External Director 11/17/2014
FibroGen, Inc. (FGEN) Announces Full Exercise Of Greenshoe Option 11/17/2014
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report - Reports Further Improved Strong Cash Position Sufficient For Clinical Trials Of Its First Two Drug Candidates 11/17/2014
Zoetis (ZTS) Adopts One-Year Shareholder Rights Plan 11/17/2014
Akebia Therapeutics, Inc. (AKBA) President And Chief Executive Officer Establishes Stock Purchase Plan 11/17/2014
GTx, Inc. (GTXI) Announces Closing Of $43.4 Private Placement 11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014
Patent Fight Between Amgen (AMGN) And Sanofi (SAN.PA)/Regeneron (REGN) Getting Murkier, Says Analyst 11/14/2014
With Promising New Gout Treatment In Its Pipeline, 2015 Will Be Big Year For CymaBay Therapeutics 11/14/2014
Tekla Life Sciences Investors Declares Stock Distribution 11/14/2014
Trillium Therapeutics Inc. Provides Corporate Update And Announces Reverse Stock Split For NASDAQ Listing 11/14/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Third Quarter 2014 Financial Results 11/14/2014
Pfenex Inc. (PFNX) Reports Third Quarter 2014 Results And Provides Business Update 11/14/2014
PTC Therapeutics, Inc. (PTCT) To Webcast Upcoming Science Day And Investor Conferences 11/14/2014
Horizon Pharma plc.  (HZNP) Announces Proposed Secondary Offering Of Ordinary Shares By Selling Shareholders 11/14/2014
Easton Pharmaceuticals (OP: EAPH) Engages Accredited Independent Auditor To Commence An Audit Of Company's Financial Statement Or Years Ending 2013 And 2014 11/14/2014
Tokai Pharmaceuticals (TKAI) To Ring The Nasdaq Stock Market Opening Bell 11/14/2014
DS Healthcare Group Issues Letter To Shareholders 11/14/2014
Analyst: Amgen (AMGN)’s Psoriasis Drug Is Superior To Stelara And Sales Will Reflect That 11/13/2014
Gilead Sciences, Inc. (GILD) Prices $4 Billion Of Senior Unsecured Notes 11/13/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 11/13/2014
Coherus Biosciences Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 11/13/2014
PRA Health Sciences Announces Pricing Of Its Initial Public Offering 11/13/2014
Roche Holding AG (RHHBF.PK) Announces Pricing Of Its Debt Tender Offer 11/13/2014
Amgen (AMGN) To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions 11/13/2014
Mast Therapeutics (MSTX) Announces Closing Of Underwritten Public Offering 11/13/2014
Roche (RHHBY) Announces Early Tender Results Of Its Debt Tender Offer 11/13/2014
Bioniche Life Sciences Inc. (BNC) Announces Results Of Annual General Meeting Of Shareholders 11/13/2014
Dow Outlines Next Layer Of Strategic Actions At Investor Forum 2014 11/13/2014
Cellectis (ALCLS) Received Proceeds of €13 Million Through The Exercise Of Warrants 11/13/2014
Regeneron (REGN), Sanofi (SAN.PA) Asthma Drug A Potential Blockbuster For Allergies, Says Analyst 11/12/2014
Isis Pharmaceuticals, Inc. (ISIS) Prices Offering Of $425 Million Of 1.00% Convertible Senior Notes 11/12/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Bioniche Life Sciences Inc. (BNC) Reports MCNA Update & First Quarter Results 11/12/2014
Affymetrix (Santa Clara, California) (AFFX) Announces Webcast Of Investor Day 2014 On Monday November 17, 2014 11/12/2014
Extraordinary General Meeting Held In Nordic Nanovector ASA 11/12/2014
Nevro Corp Announces Full Exercise Of Over-Allotment Option And Closing Of Initial Public Offering 11/12/2014
PTC To Ring The Nasdaq Stock Market Closing Bell 11/12/2014
Allergan Inc. (AGN) Board Of Directors Announces Approval Of Amendments To Company’s Bylaws 11/12/2014
Citi: Esperion Therapeutics, Inc. (ESPR) Will See Cancer Drug Data By End Of Year 11/11/2014
Gilead Sciences, Inc. (GILD) Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst 11/11/2014
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2014 And To Provide A Business Update 11/11/2014
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Offering Of $425 Million of Convertible Senior Notes 11/11/2014
Daiichi Sankyo, Inc. (4568.t) And Ambit Biosciences Announce Results Of Tender Offer 11/11/2014
Acasti Pharma Receives NASDAQ Notification Regarding Minimum Bid Requirements 11/11/2014
WuXi PharmaTech Co., Ltd. Announces Shareholder Resolutions Adopted At 2014 Annual General Meeting 11/11/2014
EPIRUS Biopharmaceuticals Reports Third Quarter Results And Provides Corporate Update 11/11/2014
Ophthotech Corporation (OPHT) Provides Business Update And Reports Third Quarter 2014 Financial Results 11/11/2014
Analyst: Celgene (CELG)’s Drug Pipeline Will Be The Gift That Keeps On Giving 11/10/2014
INC Research, Inc. To Ring The Nasdaq Stock Market Opening Bell In Celebration Of IPO 11/10/2014
Mirati Therapeutics  (MRTX) Reports Third Quarter 2014 Financial Results And Provides Business Update 11/10/2014
Dynavax Technologies Corporation (DVAX) Announces One-for-Ten Reverse Stock Split 11/10/2014
Centene Corporation To Provide 2015 Financial Guidance And Host Investor Meeting In NYC On December 12, 2014 11/10/2014
DelMar Pharmaceuticals Announces September 30, 2014 Results And Provides Corporate Update 11/10/2014
AB Science (AB.PA): Masitinib In Mastocytosis - Summary Of Web Conference 11/10/2014
GTX Corp Provides Corporate Update And Reports Third Quarter 2014 Financial Results 11/10/2014
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014
GENFIT Corp. (ALGFT) To Participate In Three Upcoming Investor Conferences 11/7/2014
Capricor Therapeutics, Inc. To Hold Duchenne Muscular Dystrophy Data Presentation Call On November 18, 2014 At 9:30 A.M. ET 11/7/2014
TherapeuticsMD, Inc.  (TXMD) Looking At Lower Cash Burn, Higher Upside From Promising HRT Therapies: Cowen 11/7/2014
CTI BioPharma Prices Underwritten Public Offering Of $35 Million Of Convertible Preferred Stock 11/7/2014
Coronado Biosciences (CNDO) Raises $3.5 Million Through The Private Placement Of Restricted Common Stock 11/7/2014
CTI BioPharma Announces Proposed Public Offering Of Convertible Preferred Stock 11/7/2014
CytoSorbents, Inc. Issues Shareholder Update Letter On Consent Solicitation Statement And Up-Listing Plans 11/7/2014
Bristol-Myers Squibb Company (BMY), Merck & Co. (MRK) Competing Hodgkin’s Drugs Look Comparable, Says Analyst 11/7/2014
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of Third Quarter 2014 Financials 11/6/2014
Nevro Corp Announces Pricing of Initial Public Offering 11/6/2014
Chimerix, Inc. (CMRX) Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 11/6/2014
ADMA Biologics, Inc. Approved For Trading On NASDAQ 11/6/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Third Quarter 2014 Financial Results 11/6/2014
PTC Therapeutics, Inc. (PTCT) Reports Third Quarter Financial Results And Provides Corporate Update 11/6/2014
Pfenex Inc. (PFNX) To Report Third Quarter 2014 Results And Provide Business Update On Thursday, November 13, 2014 11/6/2014
Mast Therapeutics (MSTX) Announces Pricing Of Underwritten Public Offering 11/6/2014
Coherus Biosciences Prices Initial Public Offering Of $85 Million Of Common Stock 11/6/2014
Sangui BioTech International Inc. (SGBI) Officially Approved As Trading On OTCQB 11/6/2014
Thermo Fisher Scientific (TMO) Announces Offering Of Dollar-Denominated Senior Notes 11/6/2014
Meda AB (MEDA-A.ST) Extraordinary General Meeting Bulletin 11/6/2014
Tekmira (TKMR) To Host Analyst Day On November 21 In New York City 11/6/2014
Pharmacyclics, Inc. (PCYC), AstraZeneca PLC (AZN) Partnership Holds Tumor Promise: Citi 11/6/2014
Mast Therapeutics (MSTX) Announces Underwritten Public Offering 11/5/2014
Quintiles Transnational Corp. Announces Launch of Secondary Public Offering And Repurchase Of Common Stock 11/5/2014
Rand Capital Increases Net Asset Value To $4.47, One New Investment In Crashmob, Inc., Two Follow-On Investments, Sale Of QuaDPharma And Continued Stock Repurchase Plan 11/5/2014
Under Immense Pressure, Amgen (AMGN) Outlines Strategy 11/5/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program 11/5/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Nasdaq Notice Of Deficiency 11/5/2014
Galmed Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 7, 2014 In New York City 11/5/2014
Karolinska Development AB Secures Funding From CP Group, A Leading Asian Life Science Investor, And Initiates Preparation For A Convertible Bond Issue 11/5/2014
Update to The Medicines Company (MDCO) Investor & Analyst Day On November 5 11/5/2014
Merck Animal Health Provides Update On Zilmax Five-Step Plan, Announces Next Steps 11/5/2014
Regulus Therapeutics, Inc. (RGLS) Announces Closing of Public Offering Of $103.5M Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 11/4/2014
NeuroDerm Announces Launch Of Initial Public Offering 11/4/2014
ULURU Inc. Provides Business Update 11/4/2014
Nordic Nanovector: Extraordinary General Meeting On 12 November 2014 11/4/2014
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences 11/4/2014
StemCells Inc. (STEM) To Host Inaugural Investor And Analyst Event In New York 11/4/2014
Oxford Immunotec Limited (OXFD) To Host Technology Day 11/4/2014
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014
AtheroNova Inc. (AHRO.OB) Announces Closing Of Public Offering Of Common Stock And Warrants 11/3/2014
VWR, Inc. Announces Exercise Of Over-Allotment Option 11/3/2014
Sigma-Aldrich Corporation (SIAL) Announces Filing Of Definitive Proxy Statement And Date Of Special Meeting Of Stockholders 11/3/2014
TetraLogic Pharmaceuticals (TLOG) To Host Investor Forum On November 10, 2014 11/3/2014
Cellceutix (CTIX)'s New Chief Operating Officer Dr. James Alexander Addresses Shareholders 11/3/2014
Change In The Number Of Shares And Votes In Meda AB (MEDA-A.ST) 10/31/2014
AbbVie (ABBV) Might Go Shopping Again Despite Shire Breakup, Say Company Execs 10/31/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
Citi: Gilead Sciences, Inc. (GILD) Sees Blockbuster First Weeks Of Harvoni Launch 10/31/2014
Chimerix, Inc. (CMRX) Prices Public Offering Of Common Stock 10/31/2014
Dyadic International, Inc. Extends All Convertible Debt Maturity Dates 10/31/2014
Cellectis (ALCLS): Event Report: Individual Shareholders’ Meeting Held On October 23, 2014 10/31/2014
The Medicines Company (MDCO) To Webcast Investor & Analyst Day On November 5 10/31/2014
Chimerix, Inc. (CMRX) Announces Commencement Of Public Offering Of Common Stock 10/30/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears" 10/30/2014
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option 10/30/2014
Roche Holdings, Inc. Announces Debt Tender Offer 10/30/2014
Ambit Biosciences Announces Expiration Of Hart-Scott-Rodino Waiting Period 10/30/2014
Neptune Technologies & Bioressources Inc. Receives TSX Approval For Normal Course Issuer Bid 10/30/2014
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO 10/29/2014
Synergy Pharmaceuticals Announces Private Offering Of Convertible Senior Notes 10/29/2014
Corbus Pharmaceuticals, Inc. Commences Trading On OTCQB Under Ticker Symbol CRBP 10/29/2014
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi 10/29/2014
Foamix Pharmaceuticals, Ltd. (FOMX) To Host Key Opinion Leader Meeting And Webcast On November 4th In New York City 10/29/2014
Vanda Pharmaceuticals, Inc. (VNDA) Proposes Public Offering Of Common Stock 10/29/2014
Novo Nordisk A/S (NVO) - Share Repurchase Programme 10/29/2014
AtheroNova Inc. (AHRO.OB) Prices Public Offering Of Common Stock And Warrants 10/29/2014
Regulus Therapeutics, Inc. (RGLS) Announces Pricing Of Public Offering Of Common Stock 10/29/2014
Synergy Pharmaceuticals Announces Pricing Of Private Offering Of $175 Million Of 7.50% Convertible Senior Notes 10/29/2014
NeuroVive Pharmaceutical AB: Annual General Meeting 2015 And Information About Members Appointed To The Nomination Committee 10/29/2014
Merck & Co. (MRK) Execs “Downplaying” Gilead Sciences, Inc. (GILD)'s Harvoni Competitor, Says Analyst 10/28/2014
Vitae Pharmaceuticals, Inc. (VTAE) Announces Exercise Of Underwriters' Option To Purchase Additional Shares Of Initial Public Offering 10/28/2014
Repros Therapeutics Inc. (RPRX) To Webcast Investor And Analyst Day On October 31st 10/28/2014
Regulus Therapeutics, Inc. (RGLS) Announces Commencement Of Public Offering Of Common Stock 10/28/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Entry Into $20 Million "At-The-Market" Equity Distribution Agreement With Canaccord Genuity Inc. 10/28/2014
Celator Pharmaceuticals, Inc. Announces Completion Of Its Public Offering And The Exercise In Full Of Option To Purchase Additional Units Of Common Stock And Warrants To Purchase Common Stock 10/28/2014
Nordic Nanovector – Registered Share Capital Increase 10/28/2014
Sanofi (SAN.PA) Delivers Business EPS Growth of 10.3% At CER 10/28/2014
Amgen (AMGN) Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs 10/28/2014
Citi: Sarepta Therapeutics (SRPT) Will See Competition, Concern Over FDA Delay 10/27/2014
Pfizer (PFE)'s $11 Billion Buyback Dims Prospects Of AstraZeneca PLC (AZN) Bid 10/27/2014
Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc. (ALXN), Says Analyst 10/24/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen 10/24/2014
Amgen (AMGN) To Webcast 2014 Business Review Meeting On October 28 10/24/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change And Launches New Corporate Website 10/24/2014
Zafgen (ZFGN) To Ring The Nasdaq Stock Market Closing Bell 10/24/2014
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $6 Million 10/24/2014
AptarGroup Declares Quarterly Dividend 10/24/2014
Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P 10/24/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014
Innocoll AG Proposes Changes To Supervisory Board And Stock Option Plan 10/23/2014
Celator Pharmaceuticals, Inc. Announces Pricing Of A $12.9 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock 10/23/2014
Notice Of Extraordinary General Meeting Of Medivir AB (MVRBF) (Publ) 10/23/2014
TetraPhase PharmaceuticalsAnnounces Closing Of Public Offering Of Common Stock 10/23/2014
Celgene (CELG) Beats The Street Again On Earnings And Analysts Couldn’t Be Happier 10/23/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program 10/22/2014
Bioren, Inc. Announces Additional Orders For $1.7 Million 10/22/2014



//-->